RxSight, Inc. Stock Plummets to New 52-Week Low of $4.49

RxSight, Inc., a microcap company in the Electronics & Appliances industry, has reached a new 52-week low of USD 4.49 as of June 11, 2026. This significant decline marks a staggering 91.86% drop in the stock's performance over the past year, contrasting sharply with the S&P 500's gain of 22.78% during the same period. The company's financial metrics reveal a challenging landscape, with a market capitalization of USD 258 million and a price-to-book ratio of 0.94. RxSight has reported negative results for the last four consecutive quarters, including a notable decline in net sales by 18.48%. The inventory turnover ratio stands at a low of 1 time, while the debtors turnover ratio is at 4.77 times, indicating potential inefficiencies in asset management. With a return on equity of -14.13% and a debt-to-equity ratio of -0.82, RxSight's financial health appears strained. The stock's previous 52-week high was USD 14.88, highlighting the extent of its recent downturn. This performance underscores the challenges faced by the company in a competitive market environment.